Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc EDTXF


Primary Symbol: T.EDT

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Bullboard (TSX:EDT)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by hmmmmmmmmon Mar 12, 2024 3:43pm

RE:A buck 20 off Analyst target?

The only facts that have changed- were changed by management.  The 35% drop came from their statements vs their contrary actions. Much like the years of touting DIMI/ SAMI- misleading ...more  
101
Discussion
Post by Stocktreeon Mar 12, 2024 3:08pm

There was no catalyst, as there is no billion dollar market

for EDT. If the trial is a success, this play that isn't shopping around for takers and has proven many times it isn't in the business of producing and selling their goods on their own will ...more  
114
Discussion
Comment by Stocktreeon Mar 12, 2024 2:47pm

RE:RE:20 cents off last months

Haha, the pumping has restarted, now that the dumping is done. And you can't dump if you truly believe what the pumpcycles are advocating. Proof again that this is not a true market opportunity ...more  
79
Discussion
Post by mercedesmanon Mar 12, 2024 2:43pm

A buck 20 off Analyst target?

As far as I know, the facts haven't changed for this almost " completely off the radar " play.  Sub $100M USD MC for a company that may soon tap into a $2B US market?  ...more  
112
Discussion
Comment by mercedesmanon Mar 12, 2024 2:36pm

RE:20 cents off last months

Great short term buying opportunity for those that sold some in the sixties ?  MM 
68
Discussion
Post by TechOneon Mar 12, 2024 1:43pm

Spectral on Linkedin

In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America ...more  
121
Post by hmmmmmmmmon Mar 12, 2024 11:56am

20 cents off last months

lead up to Seto's "major catalyst". A reminder that the market does not like management that goes back on their stated plans/ promises. 27 days since the 90th patient was enrolled and ...more  
166
Discussion
Comment by mercedesmanon Mar 11, 2024 5:48pm

RE:RE:RE:RE:RE:MM’s Napkin Math

Hard to put odds on how it might play out. Depends how many other interested parties there are, not just in Baxters dialysis business, but in the Sepsis solution piece as well - and what value they ...more  
168
Discussion
Comment by mercedesmanon Mar 11, 2024 5:34pm

RE:RE:RE:RE:MM’s Napkin Math

Hmmmmm re: " squaring"  Try re-reading my post  In particular the last paragraph.  Also $7x 400M = $2.8M and that's before considering that Baxter is already an ...more  
140
Discussion
Post by Revtenon Mar 11, 2024 4:51pm

NUMBERS FOR THE LAST MONTH

Here are The Numbers from February 12th to March 11th.  Anonymous was Busy over the last 30 Days! Representing almost half the Total Volume......draw from it what you will.     ...more  
135
Post by Revtenon Mar 11, 2024 4:40pm

TODAY’S NUMBERS

House Positions for C:EDT from 20240311 to 20240311 House Bought $Val Ave Sold $Val Ave Net $Net ...more  
132
Post by Revtenon Mar 11, 2024 4:34pm

Numbers From March 5th to 8th

For those interested here are the Numbers from March 5th to the 8th. I posted up to the 4th. Note this combines all Totals for 4 Days.  House Positions for C:EDT from 20240305 to ...more  
97
Comment by gebremeskelon Mar 11, 2024 4:26pm

RE:RE:RE:RE:MM’s Napkin Math

The Vantive promotional material shows PMX as something they have exclusive distribution rights to in North America. The plan seems to have been for Baxter to transfer those rights to Vantive as part ...more  
128
Discussion
Comment by hmmmmmmmmon Mar 11, 2024 2:28pm

RE:RE:RE:MM’s Napkin Math

I'm curious how your math squares Vantive a company hoping to IPO at a 4.5Billion valuation, buying PMX -that you've priced at the low range of 5.13Billion (CA)? And before you pivot to ...more  
115
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities